ArticleCell discovery2020

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement.

Jinkai Zang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.